OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Detalles Bibliográficos
Autores principales: Currier, JR, De Souza, M, Ratto-Kim, S, Paris, R, Nguay, V, Cox, J, Earl, P, Moss, B, Sriplienchan, S, Thongcharoen, P, Kim, J, Robb, M, Michael, N, Marovich, M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/
http://dx.doi.org/10.1186/1742-4690-6-S3-O27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/
http://dx.doi.org/10.1186/1742-4690-6-S3-O27

Ejemplares similares